Another attractive strategy would rely on the use of inhibitors of TGF-β signaling molecules in cancer cells, such as ubiquitin-specific peptidase 8 (USP8) which is a metastasis enhancer and an active deubiquitinase in aggressive tumors (eg. breast) (35). Here, TGFB1 is linked to cancer.